Minovia Therapeutics Ltd

Active trials

• phase1A Study to Evaluate the MNV-201 in Patients With Low Risk MDSrecruitingn=15
• —Collection of Blood and Skin Samples From Patients With Primary Mitochondrial Diseases and Healthy Volunteersrecruitingn=100
• phase1A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletionwithdrawn
• phase2Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)recruitingn=6
• —Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndromeactive not recruitingn=100
• —Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapiesrecruitingn=300